NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) was identified by our screener as a strong growth stock with a favorable technical setup. The company combines solid fundamentals with a recent positive price trend, making it an interesting candidate for investors looking for growth opportunities.
Fundamental Strengths
Growth: NBIX has demonstrated strong revenue growth, increasing by 21.73% over the past year, with an average annual growth rate of 24.48% in recent years. Earnings are expected to grow by 35.48% annually in the coming years.
Profitability: The company boasts an 8.29% Return on Assets and a 12.06% Return on Equity, outperforming most peers in the biotechnology sector. Its 20.78% Operating Margin is also well above industry averages.
Financial Health: NBIX has no debt, providing stability and flexibility. Its Altman-Z score of 7.86 indicates low bankruptcy risk.
Technical Setup
Trend: Both short-term and long-term trends are positive, with the stock trading near the upper end of its recent range.
Support & Resistance: A key support zone lies between $122.84 and $124.16, while resistance is found near $125.73. A breakout above this level could signal further upside.
Volume & Momentum: Recent price action has been strong, though volume has dipped slightly in recent days.
This is not investment advice. The observations here are based on current data, but market conditions can change. Always conduct your own research before making investment decisions.